Procter & Gamble Form 144: Performance Award Shares to Be Sold on 08/19/2025

Rhea-AI Filing Summary

Procter & Gamble Company (PG) Form 144 notice discloses a proposed sale of 12,353 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $1,913,541.47. The shares are reported as acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company, with an approximate sale date of 08/19/2025. The filing lists 2,342,371,488 shares outstanding for the class. No securities of the issuer were reported sold by the person in the prior three months. The filer represents there is no undisclosed material adverse information and notes the criminal penalties for misstatement.

Positive

• Securities were acquired under a Performance Stock Program Award, which explains the lawful origin of the shares.
• Full Rule 144 fields are provided: broker, acquisition date, number of shares, aggregate market value, outstanding shares, and approximate sale date.

Negative

• None.

Insights

Financial Analyst

TL;DR: Officer/insider plans to sell newly vested performance shares totaling $1.9M the day after acquisition.

The filing documents a routine Rule 144 notice tied to a Performance Stock Program Award vested on 08/18/2025 and slated for sale on 08/19/2025 via Morgan Stanley Smith Barney LLC. The position size and timing indicate a near-term liquidity event for the reporting person rather than an ongoing disposal pattern; the filer reports no sales in the prior three months. This disclosure is procedural, meeting Rule 144 requirements to report proposed sales by persons defined under the rule.

Compliance Officer

TL;DR: Filing appears to satisfy Rule 144 disclosure elements for a planned sale following award vesting.

The notice includes required fields: acquisition date, nature of acquisition, broker, number of shares, aggregate value, outstanding shares, and approximate sale date. The representation regarding absence of undisclosed material adverse information and the warning about intentional misstatements are present. The filing does not report any prior sales in the past three months, which affects aggregation rules under Rule 144. No additional compliance deficiencies are evident within the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	12353	1913541.47	2342371488	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			22804	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for PG report?

The filing reports 12,353 shares of Procter & Gamble common stock to be sold.

When were the reported shares acquired and when is the approximate sale date?

The shares were acquired on 08/18/2025 and the approximate sale date is 08/19/2025.

What is the aggregate market value reported on the Form 144 for PG?

The aggregate market value is reported as $1,913,541.47.

Which broker is handling the proposed sale listed in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services.

How many shares outstanding does the filing list for the class?

The filing lists 2,342,371,488 shares outstanding for the common stock class.

Were any issuer securities sold by the reporting person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.